Sarepta Therapeutics (SRPT) Net Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
Sarepta Therapeutics (SRPT) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -374.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -44.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 6,620.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -13,815.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 7,793.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 9,934.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -5,319.00 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 31,387.00 |
| 10 | Sarepta Therapeutics | 2.36 Bn | 1.57 Bn | 251.87 Mn | 795.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 795.00 |
| Mar 31, 2026 | 24,914.00 |
| Dec 31, 2025 | -2,143.00 |
| Sep 30, 2025 | 6,687.00 |
| Jun 30, 2025 | 13,137.00 |
| Mar 31, 2025 | -1,027.00 |
| Dec 31, 2024 | 8,467.00 |
| Sep 30, 2024 | 3,261.00 |
| Jun 30, 2024 | 5,148.00 |
| Mar 31, 2024 | 12,267.00 |
| Dec 31, 2023 | 14,191.00 |
| Sep 30, 2023 | 12,418.00 |
| Jun 30, 2023 | 10,063.00 |
| Mar 31, 2023 | -18,846.00 |
| Dec 31, 2022 | 19,293.00 |
| Sep 30, 2022 | 1,562.00 |
| Jun 30, 2022 | 19,283.00 |
| Mar 31, 2022 | 3,827.00 |
| Dec 31, 2021 | 10,636.00 |
| Sep 30, 2021 | 7,191.00 |